People: Chindex International Inc (CHDX.O)
CHDX.O on Nasdaq
15.70USD
2:41pm EDT
15.70USD
2:41pm EDT
Price Change (% chg)
$-0.34 (-2.12%)
$-0.34 (-2.12%)
Prev Close
$16.04
$16.04
Open
$16.01
$16.01
Day's High
$16.11
$16.11
Day's Low
$15.70
$15.70
Volume
8,751
8,751
Avg. Vol
26,469
26,469
52-wk High
$16.62
$16.62
52-wk Low
$8.94
$8.94
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Kenneth Nilsson |
79 | 2004 | Independent Chairman of the Board |
Roberta Lipson |
57 | 2004 | President, Chief Executive Officer, Director |
Robert Low |
57 | 2012 | Chief Financial Officer, Senior Vice President - Finance, Corporate Controller |
Lawrence Pemble |
54 | 2012 | Chief Operating Officer, Executive Vice President, Director |
Elyse Silverberg |
55 | 1981 | Executive Vice President, Secretary, Director |
Holli Harris |
45 | 2004 | Independent Director |
Carol Kaufman |
63 | 2000 | Independent Director |
Julius Oestreicher |
81 | 1996 | Independent Director |
Biographies
| Name | Description |
|---|---|
Kenneth Nilsson |
Mr. Kenneth A. Nilsson is Independent Chairman of the Board of Chindex International, Inc., since October 2004. Mr. Nilsson formerly served as President of Cooper Laboratories, Inc.; President of Cooper Lasersonics, Inc.; Managing Director of Pfizer Taito Ltd.; President of Max Factor, Japan; and Chairman of the Monterey Institute of International Studies. Mr. Nilsson also serves on the boards of AAA Club Partners and AAA of Northern California, Nevada and Utah. Mr. Nilsson received a B.A. degree from the University of Southern California and an M.A. degree from the University of California. |
Roberta Lipson |
Ms. Roberta Lipson is President, Chief Executive Officer, Director of Chindex International Inc. Ms. Lipson is co-founded the Company in 1981. Ms. Lipson has served as the Chief Executive Officer and a Director since 1981, and as the Chairman of the Board of Directors from 1981 until 2004. From 1979 until founding the Company in 1981, Ms. Lipson was employed in China by Sobin Chemical, Inc., a worldwide trading company, as Marketing Manager, coordinating marketing and sales of various equipment in China. Ms. Lipson was employed by Schering-Plough Corp. in the area of product marketing until 1979. Ms. Lipson received a B.A. degree in East Asian Studies from Brandeis University and an MBA degree from Columbia University Graduate School of Business. |
Robert Low |
Mr. Robert C. Low, CPA, is Chief Financial Officer, Senior Vice President - Finance, Corporate Controller of Chindex International, Inc. He joined the Company in September 2008 and has served as Senior Vice President, Finance, Chief Financial Officer and Corporate Controller since January 2012. He served as Vice President, Finance, Chief Accounting Officer and Controller from November 2008 through December 2011. Prior to joining the Company, Mr. Low was employed by Middlebrook Pharmaceuticals, Inc., which develops anti-infectious drug products, from 2006 to 2008 as Vice President, Chief Financial Officer and Treasurer and from 2003 to 2006 as Corporate Controller. In April 2010, Middlebrook Pharmaceuticals filed a voluntary petition for bankruptcy protection under Chapter 11 of the U.S. Bankruptcy Code. Prior to his employment at Middlebrook, Mr. Low worked in various capacities in public and private accounting. Mr. Low is a Certified Public Accountant, holding a B.A. degree in Economics from the University of Pennsylvania and an MBA degree in Finance from the University of Houston. |
Lawrence Pemble |
Mr. Lawrence Pemble is Chief Operating Officer, Executive Vice President, Director of Chindex International, Inc. He joined the Company in 1984 and has served as Executive Vice President and Chief Operating Officer since January 2012. He served as Executive Vice President and Chief Financial Officer from January 1996 through December 2011. He has also served as Chief Financial Officer of CML since its formation in December 2010. From 1986 through April 1992 and September 1993 to the present, Mr. Pemble has also served as a Director of the Company. Prior to joining the Company, Mr. Pemble was employed by China Books and Periodicals, Inc. as Manager, East Coast Center. Mr. Pemble holds a B.S. degree in Business and Accounting from the University of Phoenix, a B.A. degree in Chinese Studies and Linguistics from the State University of New York at Albany and an MBA degree from the University of Michigan. |
Elyse Silverberg |
Ms. Elyse Beth Silverberg is Executive Vice President, Secretary, Director of Chindex International, Inc. She co-founded the Company in 1981. Ms. Silverberg has served as the Company’s Executive Vice President and Secretary and as a Director since that time. She has also served as Chief Operating Officer of the Company’s Chindex Medical Limited (CML) joint venture since its formation in December 2010. Prior to founding the Company, Ms. Silverberg worked with Ms. Lipson at Sobin Chemical, Inc. from 1980 to 1981 and was an intern in China with the National Council for U.S.-China Trade from 1979 to 1980. Ms. Silverberg received a B.A. degree in Chinese Studies and History from the State University of New York at Albany. |
Holli Harris |
Ms. Holli Harris is Independent Director of Chindex International, Inc., since August 2004. Ms. Harris worked for the U.S. State Department at the U.S. Embassy in Moscow, and has since served in financial and strategic management positions in the energy, banking, biotech and automotive industries. In 2003, Ms. Harris was a Financial Analyst with Amgen Inc., an international biotechnology and pharmaceutical firm. From 2004 to 2008, Ms. Harris was a Financial Manager at Corbis Corporation, an international visual and image solutions provider. Ms. Harris currently is a small business owner and an independent business strategy and process consultant. Ms. Harris has a dual degree in Russian Language and International Relations from the University of California - Davis and an MBA degree in Finance from the University of Michigan. |
Carol Kaufman |
Ms. Carol R. Kaufman is Independent Director of Chindex International, Inc., since November 2000. Ms. Kaufman has been an officer, including Chief Administrative Officer, of The Cooper Companies, Inc., a medical device company, since October 1995, including being elected Vice President of Legal Affairs in March 1996, Senior Vice President in October 2004 and Executive Vice President and Secretary since July 2011. From January 1989 through September 1995, she served as Vice President, Secretary and Chief Administrative Officer of Cooper Development Company, a healthcare and consumer products company that was a former affiliate of The Cooper Companies, Inc. Beginning in 1971, she held a variety of financial positions, including Deputy Corporate Controller, with Cooper Laboratories, Inc., the former parent of The Cooper Companies, Inc. Ms. Kaufman received her undergraduate degree from Boston University. |
Julius Oestreicher |
Mr. Julius Y. Oestreicher is Independent Director of Chindex International, Inc., since January 1996. Mr. Oestreicher has been a partner with the law firm of Oestreicher, Ennis, Dalrymple & Dalrymple, LLP and its predecessor firms for more than thirty years, engaging primarily in estate, tax and business law. Mr. Oestreicher received a B.B.A. degree in Business Administration from City College of New York and a J.D. degree from Fordham University School of Law. He is also a Certified Public Accountant. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Kenneth Nilsson |
-- |
Roberta Lipson |
1,314,170 |
Robert Low |
556,953 |
Lawrence Pemble |
1,127,200 |
Elyse Silverberg |
1,130,370 |
Holli Harris |
-- |
Carol Kaufman |
-- |
Julius Oestreicher |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
Kenneth Nilsson |
0 | 0 |
Roberta Lipson |
305,000 | 2,502,433 |
Robert Low |
0 | 0 |
Lawrence Pemble |
321,000 | 2,562,286 |
Elyse Silverberg |
305,000 | 2,421,903 |
Holli Harris |
0 | 0 |
Carol Kaufman |
0 | 0 |
Julius Oestreicher |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
LIPSON ROBERTA |
46,900 | $0.00 |
SILVERBERG ELYSE BETH |
46,900 | $0.00 |
PEMBLE LAWRENCE |
46,900 | $0.00 |
LOW ROBERT C |
16,080 | $0.00 |
OESTREICHER JULIUS Y |
1,000 | $10.50 |
OESTREICHER JULIUS Y |
1,000 | $10.50 |
OESTREICHER JULIUS Y |
1,000 | $10.48 |
OESTREICHER JULIUS Y |
3,000 | $10.37 |
HARRIS HOLLI |
5,985 | $10.35 |
OESTREICHER JULIUS Y |
5,000 | $10.37 |
HARRIS HOLLI |
15 | $10.45 |
OESTREICHER JULIUS Y |
5,000 | $10.36 |
LIPSON ROBERTA |
3,526 | $10.04 |
SILVERBERG ELYSE BETH |
3,085 | $10.04 |
LOW ROBERT C |
1,610 | $10.04 |
PEMBLE LAWRENCE |
4,112 | $10.04 |
OESTREICHER JULIUS Y |
36,000 | $1.27 |
LOW ROBERT C |
403 | $10.44 |
LIPSON ROBERTA |
1,653 | $10.44 |
PEMBLE LAWRENCE |
1,763 | $10.44 |
SILVERBERG ELYSE BETH |
1,323 | $10.44 |
KAUFMAN CAROL R |
7,807 | $10.53 |
KAUFMAN CAROL R |
5,000 | $10.41 |
KAUFMAN CAROL R |
7,233 | $10.50 |
KAUFMAN CAROL R |
3,100 | $10.51 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
